- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-DCLK1
DCLK1 Polyclonal Antibody for WB, IP, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris
Applications
WB, IP, IF, FC, IHC, ELISA
Conjugaison
Non conjugué
N° de cat : 21699-1-AP
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | tissu cérébral de rat, tissu cérébral de souris, tissu cérébral humain |
Résultats positifs en IP | tissu cérébral de rat |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:3000 |
Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 3 publications below |
WB | See 7 publications below |
IHC | See 1 publications below |
IF | See 5 publications below |
IP | See 1 publications below |
FC | See 1 publications below |
Informations sur le produit
21699-1-AP cible DCLK1 dans les applications de WB, IP, IF, FC, IHC, ELISA et montre une réactivité avec des échantillons Humain, rat, souris
Réactivité | Humain, rat, souris |
Réactivité citée | Humain, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | DCLK1 Protéine recombinante Ag16292 |
Nom complet | doublecortin-like kinase 1 |
Masse moléculaire calculée | 729 aa, 81 kDa |
Poids moléculaire observé | 48 kDa, 82 kDa |
Numéro d’acquisition GenBank | BC152456 |
Symbole du gène | DCLK1 |
Identification du gène (NCBI) | 9201 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
DCLK1 (Serine/threonine-protein kinase DCLK1) is also named as DCAMKL1, DCDC3A, KIAA0369 and belongs to the CAMK Ser/Thr protein kinase family. It is a microtubule-associated kinase that can undergo autophosphorylation and it also has microtubule-polymerizing activity that is independent of its protein kinase activity (PMID: 11124993). It plays a unique role in mitotic spindle integrity during early neurogenesis in radial glial cell proliferation and their radial process stability. DCLK1 is a unique marker for distinguishing tumor stem cells from intestinal normal stem cells (PMID: 23202126). This protein has 4 isoforms produced by alternative splicing with the molecular weight of 82 kDa, 81 kDa, 47 kDa and 48 kDa.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for DCLK1 antibody 21699-1-AP | Download protocol |
IP protocol for DCLK1 antibody 21699-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Immunity Intestinal Tuft-2 cells exert antimicrobial immunity via sensing bacterial metabolite N-undecanoylglycine. | ||
Redox Biol FUT2-dependent fucosylation of HYOU1 protects intestinal stem cells against inflammatory injury by regulating unfolded protein response | ||
Clin Transl Med Targeting DCLK1 overcomes 5-fluorouracil resistance in colorectal cancer through inhibiting CCAR1/β-catenin pathway-mediated cancer stemness.
| ||
J Gastroenterol High-throughput screening identified miR-7-2-3p and miR-29c-3p as metastasis suppressors in gallbladder carcinoma.
| ||
Front Pharmacol XMD-17-51 Inhibits DCLK1 Kinase and Prevents Lung Cancer Progression.
| ||
Cell Physiol Biochem MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1. |